Alimera Announces Multiple Abstracts Highlighting ILUVIEN® Real World Data at EURETINA Annual Congress
Positive findings from the RIVER study and data on retreatment with ILUVIEN available ATLANTA, Aug….
Year: 2022
AVEO Oncology Announces Participation at Investor Conferences in September
BOSTON, Aug. 31, 2022 (GLOBE NEWSWIRE) — AVEO Oncology (Nasdaq: AVEO), a commercial stage, oncology-focused…
U.S. Food and Drug Administration (FDA) Grants Fast Track Designation for Longeveron’s Lomecel-B™ Product for Treatment of Hypoplastic Left Heart Syndrome (HLHS) in Infants
New designation may expedite FDA review and potential approval to address this life-threatening heart condition…
Vaxart Names Biotech Veteran Ray Stapleton Chief Technology Officer
Dr. Stapleton has more than 20 years of industry experience leading technical, quality and manufacturing…
Blue Water Vaccines to Present at H.C. Wainwright’s 24th Annual Global Investment Conference in New York, NY
CINCINNATI, Aug. 31, 2022 (GLOBE NEWSWIRE) — Blue Water Vaccines Inc. (“BWV” or “Blue Water…
X4 Pharmaceuticals to Host Investor Webinar Highlighting New Mavorixafor Phase 1b Data in Chronic Neutropenia
Webcast to take place on September 27 at 8:00 a.m. ET, followed by live Q&A…
Ascendis Pharma Submits TransCon™ PTH New Drug Application to the U.S. FDA for Adult Patients with Hypoparathyroidism
• TransCon PTH could, if approved, become the first hormone replacement therapy to address the…
Akoya to Participate at Four Upcoming Investor Conferences
MARLBOROUGH, Mass., Aug. 31, 2022 (GLOBE NEWSWIRE) — Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The…
Araris Biotech AG to Present at 13th Annual World ADC San Diego 2022
AU ZH, Switzerland, Aug. 31, 2022 (GLOBE NEWSWIRE) — Araris Biotech AG, a company pioneering…
New Study Published in Clinical Cancer Research Journal Highlights Use of EndoPredict Test to Inform Treatment for Premenopausal Breast Cancer Patients
Myriad Genetics’ EndoPredict test accurately identified premenopausal women with ER+, HER2- breast cancer who could…
CRISPR Therapeutics to Participate in Upcoming Investor Conferences
ZUG, Switzerland and CAMBRIDGE, Mass., Aug. 31, 2022 (GLOBE NEWSWIRE) — CRISPR Therapeutics (Nasdaq: CRSP),…
Rain Therapeutics to Participate in Citi’s 17th Annual BioPharma Conference
NEWARK, Calif., Aug. 31, 2022 (GLOBE NEWSWIRE) — Rain Therapeutics Inc. (NasdaqGS: RAIN), (“Rain”), a…
Madrigal Pharmaceuticals Initiates the MAESTRO-NASH Outcomes Study Evaluating Resmetirom for the Treatment of Patients with Compensated NASH Cirrhosis
CONSHOHOCKEN, Pa., Aug. 31, 2022 (GLOBE NEWSWIRE) — Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a clinical-stage biopharmaceutical…
Hepion Pharmaceuticals Announces Initiation of Phase 2b ‘ASCEND-NASH’ Trial
– Hepion Screens First Subject in Biopsy-Confirmed F2/F3 NASH Study – – Subjects will be…
Mindset Pharma Further Expands its IP Portfolio with Three Additional Non-Tryptamine Families of Next-Generation Psychedelic Compounds
Expands Discovery Pipeline with Three Additional Chemically Distinct Families of Highly Novel, Non-Tryptamine Drug Candidate…
Verizon goes back to school with new immersive learning content
New tech-driven lesson plans, AR/VR apps, school partners and lab openings launch under Verizon Innovative…
CodeSee Launches First-of-its-Kind Code Visibility Platform for the Enterprise
CodeSee Enterprise Makes It Easier Than Ever to Visualize and Automate Code Knowledge Across the…
Ahana Joins Leading Open Source Innovators in its Commitment to the Velox Open Source Project Created by Meta
Extends engineering resources and names significant contributors SAN MATEO, Calif., Aug. 31, 2022 (GLOBE NEWSWIRE)…
Esports Entertainment Group CEO Grant Johnson to Speak at Next World Forum – Gaming & Esports Unleashed in Riyadh
Event hosted by the Saudi Esports Federation to focus on new opportunities in gaming and…
Universal Medical (2666.HK) Announces 2022 Interim Results
HONG KONG, Aug 31, 2022 – (ACN Newswire) – The board of directors of Genertec…